Diabetic Gastroparesis Market - Global Outlook and Forecast 2021-2027

March 2021 | 92 pages | ID: D2DE30FA1E13EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Diabetic Gastroparesis in Global, including the following market information:

Global Diabetic Gastroparesis Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Diabetic Gastroparesis market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Gastroparesis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Gastroparesis Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Diabetic Gastroparesis Market Segment Percentages, By Type, 2020 (%)

• Drugs
• Surgical Treatment Products

China Diabetic Gastroparesis Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Diabetic Gastroparesis Market Segment Percentages, By Application, 2020 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Diabetic Gastroparesis Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Diabetic Gastroparesis Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Diabetic Gastroparesis Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Diabetic Gastroparesis Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Medtronic
• Sumitomo Dainippon Pharma
• Abbott Laboratories
• Boston Scientific Corporation
• C. R. Bard, Inc
• Janssen Global Services, LLC
• Alfasigma SpA
• Evoke Pharma
• Cadila Pharmaceuticals
• Sanofi
• Teva Pharmaceutical Industries Ltd
• Pfizer
• Vanda Pharmaceuticals
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetic Gastroparesis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetic Gastroparesis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETIC GASTROPARESIS OVERALL MARKET SIZE

2.1 Global Diabetic Gastroparesis Market Size: 2021 VS 2027
2.2 Global Diabetic Gastroparesis Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetic Gastroparesis Players in Global Market
3.2 Top Global Diabetic Gastroparesis Companies Ranked by Revenue
3.3 Global Diabetic Gastroparesis Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Gastroparesis Companies in Global Market, by Revenue in 2020
3.5 Global Companies Diabetic Gastroparesis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Gastroparesis Players in Global Market
  3.6.1 List of Global Tier 1 Diabetic Gastroparesis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Diabetic Gastroparesis Market Size Markets, 2021 & 2027
  4.1.2 Drugs
  4.1.3 Surgical Treatment Products
4.2 By Type - Global Diabetic Gastroparesis Revenue & Forecasts
  4.2.1 By Type - Global Diabetic Gastroparesis Revenue, 2016-2021
  4.2.2 By Type - Global Diabetic Gastroparesis Revenue, 2022-2027
  4.2.3 By Type - Global Diabetic Gastroparesis Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetic Gastroparesis Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Diabetic Gastroparesis Revenue & Forecasts
  5.2.1 By Application - Global Diabetic Gastroparesis Revenue, 2016-2021
  5.2.2 By Application - Global Diabetic Gastroparesis Revenue, 2022-2027
  5.2.3 By Application - Global Diabetic Gastroparesis Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Diabetic Gastroparesis Market Size, 2021 & 2027
6.2 By Region - Global Diabetic Gastroparesis Revenue & Forecasts
  6.2.1 By Region - Global Diabetic Gastroparesis Revenue, 2016-2021
  6.2.2 By Region - Global Diabetic Gastroparesis Revenue, 2022-2027
  6.2.3 By Region - Global Diabetic Gastroparesis Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Diabetic Gastroparesis Revenue, 2016-2027
  6.3.2 US Diabetic Gastroparesis Market Size, 2016-2027
  6.3.3 Canada Diabetic Gastroparesis Market Size, 2016-2027
  6.3.4 Mexico Diabetic Gastroparesis Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Diabetic Gastroparesis Revenue, 2016-2027
  6.4.2 Germany Diabetic Gastroparesis Market Size, 2016-2027
  6.4.3 France Diabetic Gastroparesis Market Size, 2016-2027
  6.4.4 U.K. Diabetic Gastroparesis Market Size, 2016-2027
  6.4.5 Italy Diabetic Gastroparesis Market Size, 2016-2027
  6.4.6 Russia Diabetic Gastroparesis Market Size, 2016-2027
  6.4.7 Nordic Countries Diabetic Gastroparesis Market Size, 2016-2027
  6.4.8 Benelux Diabetic Gastroparesis Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Diabetic Gastroparesis Revenue, 2016-2027
  6.5.2 China Diabetic Gastroparesis Market Size, 2016-2027
  6.5.3 Japan Diabetic Gastroparesis Market Size, 2016-2027
  6.5.4 South Korea Diabetic Gastroparesis Market Size, 2016-2027
  6.5.5 Southeast Asia Diabetic Gastroparesis Market Size, 2016-2027
  6.5.6 India Diabetic Gastroparesis Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Diabetic Gastroparesis Revenue, 2016-2027
  6.6.2 Brazil Diabetic Gastroparesis Market Size, 2016-2027
  6.6.3 Argentina Diabetic Gastroparesis Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetic Gastroparesis Revenue, 2016-2027
  6.7.2 Turkey Diabetic Gastroparesis Market Size, 2016-2027
  6.7.3 Israel Diabetic Gastroparesis Market Size, 2016-2027
  6.7.4 Saudi Arabia Diabetic Gastroparesis Market Size, 2016-2027
  6.7.5 UAE Diabetic Gastroparesis Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Medtronic
  7.1.1 Medtronic Corporate Summary
  7.1.2 Medtronic Business Overview
  7.1.3 Medtronic Diabetic Gastroparesis Major Product Offerings
  7.1.4 Medtronic Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.1.5 Medtronic Key News
7.2 Sumitomo Dainippon Pharma
  7.2.1 Sumitomo Dainippon Pharma Corporate Summary
  7.2.2 Sumitomo Dainippon Pharma Business Overview
  7.2.3 Sumitomo Dainippon Pharma Diabetic Gastroparesis Major Product Offerings
  7.2.4 Sumitomo Dainippon Pharma Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.2.5 Sumitomo Dainippon Pharma Key News
7.3 Abbott Laboratories
  7.3.1 Abbott Laboratories Corporate Summary
  7.3.2 Abbott Laboratories Business Overview
  7.3.3 Abbott Laboratories Diabetic Gastroparesis Major Product Offerings
  7.3.4 Abbott Laboratories Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.3.5 Abbott Laboratories Key News
7.4 Boston Scientific Corporation
  7.4.1 Boston Scientific Corporation Corporate Summary
  7.4.2 Boston Scientific Corporation Business Overview
  7.4.3 Boston Scientific Corporation Diabetic Gastroparesis Major Product Offerings
  7.4.4 Boston Scientific Corporation Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.4.5 Boston Scientific Corporation Key News
7.5 C. R. Bard, Inc
  7.5.1 C. R. Bard, Inc Corporate Summary
  7.5.2 C. R. Bard, Inc Business Overview
  7.5.3 C. R. Bard, Inc Diabetic Gastroparesis Major Product Offerings
  7.5.4 C. R. Bard, Inc Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.5.5 C. R. Bard, Inc Key News
7.6 Janssen Global Services, LLC
  7.6.1 Janssen Global Services, LLC Corporate Summary
  7.6.2 Janssen Global Services, LLC Business Overview
  7.6.3 Janssen Global Services, LLC Diabetic Gastroparesis Major Product Offerings
  7.6.4 Janssen Global Services, LLC Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.6.5 Janssen Global Services, LLC Key News
7.7 Alfasigma SpA
  7.7.1 Alfasigma SpA Corporate Summary
  7.7.2 Alfasigma SpA Business Overview
  7.7.3 Alfasigma SpA Diabetic Gastroparesis Major Product Offerings
  7.4.4 Alfasigma SpA Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.7.5 Alfasigma SpA Key News
7.8 Evoke Pharma
  7.8.1 Evoke Pharma Corporate Summary
  7.8.2 Evoke Pharma Business Overview
  7.8.3 Evoke Pharma Diabetic Gastroparesis Major Product Offerings
  7.8.4 Evoke Pharma Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.8.5 Evoke Pharma Key News
7.9 Cadila Pharmaceuticals
  7.9.1 Cadila Pharmaceuticals Corporate Summary
  7.9.2 Cadila Pharmaceuticals Business Overview
  7.9.3 Cadila Pharmaceuticals Diabetic Gastroparesis Major Product Offerings
  7.9.4 Cadila Pharmaceuticals Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.9.5 Cadila Pharmaceuticals Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Diabetic Gastroparesis Major Product Offerings
  7.10.4 Sanofi Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.10.5 Sanofi Key News
7.11 Teva Pharmaceutical Industries Ltd
  7.11.1 Teva Pharmaceutical Industries Ltd Corporate Summary
  7.11.2 Teva Pharmaceutical Industries Ltd Business Overview
  7.11.3 Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Major Product Offerings
  7.11.4 Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.11.5 Teva Pharmaceutical Industries Ltd Key News
7.12 Pfizer
  7.12.1 Pfizer Corporate Summary
  7.12.2 Pfizer Business Overview
  7.12.3 Pfizer Diabetic Gastroparesis Major Product Offerings
  7.12.4 Pfizer Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.12.5 Pfizer Key News
7.13 Vanda Pharmaceuticals
  7.13.1 Vanda Pharmaceuticals Corporate Summary
  7.13.2 Vanda Pharmaceuticals Business Overview
  7.13.3 Vanda Pharmaceuticals Diabetic Gastroparesis Major Product Offerings
  7.13.4 Vanda Pharmaceuticals Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.13.5 Vanda Pharmaceuticals Key News
7.14 Allergan
  7.14.1 Allergan Corporate Summary
  7.14.2 Allergan Business Overview
  7.14.3 Allergan Diabetic Gastroparesis Major Product Offerings
  7.14.4 Allergan Diabetic Gastroparesis Revenue in Global (2016-2021)
  7.14.5 Allergan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetic Gastroparesis Market Opportunities & Trends in Global Market
Table 2. Diabetic Gastroparesis Market Drivers in Global Market
Table 3. Diabetic Gastroparesis Market Restraints in Global Market
Table 4. Key Players of Diabetic Gastroparesis in Global Market
Table 5. Top Diabetic Gastroparesis Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Diabetic Gastroparesis Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Diabetic Gastroparesis Revenue Share by Companies, 2016-2021
Table 8. Global Companies Diabetic Gastroparesis Product Type
Table 9. List of Global Tier 1 Diabetic Gastroparesis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Diabetic Gastroparesis Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Diabetic Gastroparesis Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Diabetic Gastroparesis Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Diabetic Gastroparesis Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Diabetic Gastroparesis Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Diabetic Gastroparesis Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Diabetic Gastroparesis Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Diabetic Gastroparesis Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Diabetic Gastroparesis Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Diabetic Gastroparesis Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Diabetic Gastroparesis Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Diabetic Gastroparesis Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Diabetic Gastroparesis Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Diabetic Gastroparesis Revenue, (US$, Mn), 2022-2027
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Diabetic Gastroparesis Product Offerings
Table 32. Medtronic Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 33. Sumitomo Dainippon Pharma Corporate Summary
Table 34. Sumitomo Dainippon Pharma Diabetic Gastroparesis Product Offerings
Table 35. Sumitomo Dainippon Pharma Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 36. Abbott Laboratories Corporate Summary
Table 37. Abbott Laboratories Diabetic Gastroparesis Product Offerings
Table 38. Abbott Laboratories Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 39. Boston Scientific Corporation Corporate Summary
Table 40. Boston Scientific Corporation Diabetic Gastroparesis Product Offerings
Table 41. Boston Scientific Corporation Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 42. C. R. Bard, Inc Corporate Summary
Table 43. C. R. Bard, Inc Diabetic Gastroparesis Product Offerings
Table 44. C. R. Bard, Inc Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 45. Janssen Global Services, LLC Corporate Summary
Table 46. Janssen Global Services, LLC Diabetic Gastroparesis Product Offerings
Table 47. Janssen Global Services, LLC Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 48. Alfasigma SpA Corporate Summary
Table 49. Alfasigma SpA Diabetic Gastroparesis Product Offerings
Table 50. Alfasigma SpA Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 51. Evoke Pharma Corporate Summary
Table 52. Evoke Pharma Diabetic Gastroparesis Product Offerings
Table 53. Evoke Pharma Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 54. Cadila Pharmaceuticals Corporate Summary
Table 55. Cadila Pharmaceuticals Diabetic Gastroparesis Product Offerings
Table 56. Cadila Pharmaceuticals Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Diabetic Gastroparesis Product Offerings
Table 59. Sanofi Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 60. Teva Pharmaceutical Industries Ltd Corporate Summary
Table 61. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Product Offerings
Table 62. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Diabetic Gastroparesis Product Offerings
Table 65. Pfizer Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 66. Vanda Pharmaceuticals Corporate Summary
Table 67. Vanda Pharmaceuticals Diabetic Gastroparesis Product Offerings
Table 68. Vanda Pharmaceuticals Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)
Table 69. Allergan Corporate Summary
Table 70. Allergan Diabetic Gastroparesis Product Offerings
Table 71. Allergan Diabetic Gastroparesis Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetic Gastroparesis Segment by Type
Figure 2. Diabetic Gastroparesis Segment by Application
Figure 3. Global Diabetic Gastroparesis Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Diabetic Gastroparesis Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Diabetic Gastroparesis Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Gastroparesis Revenue in 2020
Figure 8. By Type - Global Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 9. By Application - Global Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 10. By Region - Global Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 11. By Country - North America Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 12. US Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 16. Germany Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 17. France Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 24. China Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 28. India Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 30. Brazil Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Diabetic Gastroparesis Revenue Market Share, 2016-2027
Figure 33. Turkey Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Diabetic Gastroparesis Revenue, (US$, Mn), 2016-2027
Figure 37. Medtronic Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Sumitomo Dainippon Pharma Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Abbott Laboratories Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Boston Scientific Corporation Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. C. R. Bard, Inc Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Janssen Global Services, LLC Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Alfasigma SpA Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Evoke Pharma Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Cadila Pharmaceuticals Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Sanofi Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Teva Pharmaceutical Industries Ltd Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Pfizer Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Vanda Pharmaceuticals Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Allergan Diabetic Gastroparesis Revenue Year Over Year Growth (US$, Mn) & (2016-2021)